Contemporary Pediatrics - November 2009 - (Page 11)
NEWS UPDATE ANTIPSYCHOTICS LEAD TO WEIGHT GAIN IN PEDIATRIC PATIENTS R FOR SCHOOL MEALS IOM RELEASES NEW GUIDELINES T ediatric patients undergoing tonsillectomy are often given antibiotics after surgery to reduce pain. Researchers have generally used a 7-day course of antibiotics, but a new study has demonstrated that a 7-day course is no more effective than a 3-day course. The study, which was published in the October 2009 CONTINUED ON PAGE 12 W W W. C O N T E M P O R A R Y P E D I AT R I C S . C O M NOVEMBER 2009 C O N T E M P O R A R Y P E D I AT R I C S BLEND IMAGES/ LWA/DANN TARDIF/GET T Y IMAGES he Institute of Medicine (IOM) has released new recommendations for school meal programs in its report School Meals: Building Blocks for Healthy Children. The IOM set maximum calorie levels for breakfast and lunch and recommended that the sodium content of meals should be gradually reduced over the next 10 years. The IOM also recommended an increase in the amount of fruits, vegetables, and whole-grain breads in school meals, as well as the use of nonfat or 1% milk rather than 2% or whole milk. The American Dietetic Association (ADA) supports these new recommendations. ADA spokesperson Malena Perdomo said, “The IOM’s positive and progressive recommendations are very much in keeping with those that the American Dietetic Association has been making for a number of years to improve school meal quality. This report represents a large step toward achieving healthier eating goals for our children in schools.” Approximately 30.6 million US schoolchildren participated daily in the school lunch program in 2007, according to IOM figures. Additionally, 10.1 million children participated in the school breakfast program. esearchers have long known that treatment with second-generation antipsychotic agents is often associated with weight gain in adults. This association has now also been demonstrated in pediatric patients treated with these agents for the first time. An article in the October 28 issue of the Journal of the American Medical Association reports on a study of 205 pediatric patients aged 4 to 19 years who had mood spectrum, schizophrenia spectrum, or disruptive or aggressive behavior spectrum disorders. They had not previously been treated with second-generation antipsychotic medications (including aripiprazole, olanzapine, quetiapine, and risperidone). After a median of 10.8 weeks of treatment, patients who received olanzapine had an increase in weight of 18.7 lbs, those treated with quetiapine had a weight increase of 13.4 lbs, those treated with risperidone had a weight increase of 11.7 lbs, and those treated with aripiprazole had a weight increase of 9.7 lbs. Patients in the untreated comparison group had a weight increase of 0.4 lbs. Those patients treated with olanzapine or quetiapine also had adverse changes in total cholesterol, triglycerides, nonhigh-density lipoprotein (HDL) cholesterol, and the triglyceride-HDL cholesterol ratio. Patients treated with risperidone had adverse changes in triglyceride levels. The researchers said that these results highlight the need for more frequent cardiometabolic monitoring of pediatric patients during treatment with second-generation antipsychotic medications. ANTIBIOTICS AFTER TONSILLECTOMY: SHORTER DURATION OKAY P
Table of Contents for the Digital Edition of Contemporary Pediatrics - November 2009
Contemporary Pediatrics - November 2009
Editorial Advisory Board
Dermatology: What's Your DX?
Then and Now: ADHD Treatments
Cardiovascular Risk in ADHD Pharmacotherapy
Transitioning Adolescents to Adult Care and Adulthood: Is it Time Yet? Part 1 of 2
A Pragmatic Approach to ALTEs
Developmental Surveillance and Screening Part 1 of 3
Contemporary Pediatrics - November 2009
If you would like to try to load the digital publication without using Flash Player detection, please click here.